MAM
AMPH icon

Meeder Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Meeder Asset Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-175
Closed -$5K – 840
2022
Q3 		$5K Buy
175
+5
+3% +$163 ﹤0.01% 1534
2022
Q2 		$6K Buy
170
+34
+25% +$1.21K ﹤0.01% 1551
2022
Q1 		$5K Buy
+136
New +$3.86K ﹤0.01% 1771
2021
Q4 		– Sell
-177
Closed -$3K – 1177
2021
Q3 		$3K Buy
177
+35
+25% +$685 ﹤0.01% 2052
2021
Q2 		$3K Buy
142
+8
+6% +$151 ﹤0.01% 2075
2021
Q1 		$2K Buy
134
+26
+24% +$483 ﹤0.01% 2051
2020
Q4 		$2K Sell
108
-32
-23% -$623 ﹤0.01% 1447
2020
Q3 		$3K Buy
140
+59
+73% +$1.19K ﹤0.01% 1700
2020
Q2 		$2K Sell
81
-188
-70% -$3.44K ﹤0.01% 1739
2020
Q1 		$4K Sell
269
-546
-67% -$9.5K ﹤0.01% 1842
2019
Q4 		$16K Buy
815
+82
+11% +$1.57K ﹤0.01% 1423
2019
Q3 		$15K Sell
733
-11,008
-94% -$229K ﹤0.01% 1400
2019
Q2 		$249K Sell
11,741
-3,655
-24% -$76.4K 0.02% 536
2019
Q1 		$315K Buy
15,396
+10,765
+232% +$241K 0.02% 459
2018
Q4 		$92K Buy
+4,631
New +$91.3K 0.01% 658
2018
Q3 		– Sell
-10,486
Closed -$160K – 1525
2018
Q2 		$160K Buy
10,486
+7,572
+260% +$132K 0.01% 538
2018
Q1 		$55K Buy
2,914
+294
+11% +$5.53K 0.01% 647
2017
Q4 		$50K Buy
2,620
+2,362
+916% +$44.1K ﹤0.01% 695
2017
Q3 		$5K Sell
258
-128
-33% -$2.11K ﹤0.01% 1253
2017
Q2 		$7K Buy
386
+189
+96% +$3K ﹤0.01% 1079
2017
Q1 		$3K Buy
+197
New +$3.1K ﹤0.01% 1238

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Meeder Asset Management's AMPH Position: Q4 2022 in Review

Meeder Asset Management sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2022, closing a stake of 175 shares — an estimated $5K sold.

Meeder Asset Management first reported a position in AMPH in Q1 2017 and held it in 21 quarters. The position peaked at $315K in Q1 2019. 211 funds tracked by Wall St. Rank hold AMPH as of Q4 2022.

  • Meeder Asset Management reported no remaining Amphastar Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Meeder Asset Management sold 175 Amphastar Pharmaceuticals shares in Q4 2022, an estimated $5K.
  • Meeder Asset Management first reported a position in Amphastar Pharmaceuticals in Q1 2017 and held it in 21 quarters.
  • Meeder Asset Management's Amphastar Pharmaceuticals position peaked at $315K in Q1 2019.
  • 211 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2022.

Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.